Back to search

University of British Columbia

Modulation of versican expression by smooth muscle cells and myofibroblasts in cardiovascular disease

Abstract

dc:description

Aberrant accumulation of proteoglycans, particularly versican, is a hallmark of vascular lesions and is potentially important in the development of myxomatous cardiac valve lesions. My overarching hypothesis is that the dysregulation of proteoglycan expression plays an important role in the pathogenesis of accelerated vascular disease and valvular heart disease. I tested three specific hypotheses relating to this overarching framework. First, that the overexpression of versican by smooth muscle cells (SMCs) is due to modulation of its expression by specific molecules present within the tissue microenvironment. Second, that versican is spatially associated with modified lipoproteins in human atheromatous disease. Third, that the exposure of cardiac valves to certain anorexigens (appetite suppressants) produces a proteoglycan-rich lesion morphologically distinct from lesions characterizing other valve diseases and related to the dysregulation of versican expression by myofibroblasts (MFBs). To address the first hypothesis, growth factor-mediated modulation of versican expression by rat aortic SMCs was examined. Treatment of SMCs with either epidermal growth factor (EGF) or insulin-like growth factor-I (IGF-I) significantly upregulated versican mRNA levels and increased core protein expression. Stimulation of SMCs with a combination of EGF and IGF-I further increased versican expression. The oxidative status of lipoproteins present in coronary arteries from human heart allografts and their localization relative to versican and vessel wall cells were examined to address the second hypothesis. Lipoproteins in mild and severe lesions were oxidatively modified, although certain forms of oxidative modification only appeared in severe lesions. The oxidized lipoproteins were often associated with versican and intimal SMCs. The third hypothesis was addressed by examining the geometric and compositional characteristics of normal and diseased heart valves. Valves excised from patients exposed to anorexigens exhibited a glycosaminoglycan-rich lesion distinct from lesions characterizing other myxomatous valve diseases. The myxomatous process was present in both the valve onlays and the valve proper. Myxomatous regions were rich in versican and MFBs cultured from human cardiac valve tissue expressed versican. In summary, these data provide key insights into the modulation of versican expression and lay the groundwork for future experiments aimed at further understanding the regulation of versican expression and development of potential novel therapies for the treatment of cardiovascular disorders.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Pathology
Grantor dc:publisher
University of British Columbia
Year dc:date
2002

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • McDonald, Paul Christopher

Rights

dc:rights
Statement dc:rights
  • For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use.
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/14802

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

McDonald, Paul Christopher. Modulation of versican expression by smooth muscle cells and myofibroblasts in cardiovascular disease. doctoral thesis, University of British Columbia, 2002. http://hdl.handle.net/2429/14802